Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. INNV
stocks logo

INNV

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
AI Stock Picker
AI Stock Picker

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2026Q2
FY2026Q3
FY2026Q4
228.30M
+9.23%
0.040
-139.87%
231.83M
+6.28%
0.052
-165.33%
234.23M
+5.79%
0.071
-809.3%
Estimates Revision
The market is revising Downward the revenue expectations for InnovAge Holding Corp. (INNV) for FY2026, with the revenue forecasts being adjusted by -0.93% over the past three months. During the same period, the stock price has changed by 35.88%.
Revenue Estimates for FY2026
Revise Downward
down Image
-0.93%
In Past 3 Month
EPS Estimates for FY2026
Revise Upward
up Image
+249.06%
In Past 3 Month
Stock Price
Go Up
up Image
+35.88%
In Past 3 Month
Wall Street analysts forecast INNV stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for INNV is 5.25 USD with a low forecast of 5.00 USD and a high forecast of 5.50 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
4 Analyst Rating
Wall Street analysts forecast INNV stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for INNV is 5.25 USD with a low forecast of 5.00 USD and a high forecast of 5.50 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Buy
3 Hold
1 Sell
Hold
Current: 5.150
sliders
Low
5.00
Averages
5.25
High
5.50
Current: 5.150
sliders
Low
5.00
Averages
5.25
High
5.50
JPMorgan
Underweight
initiated
$5
2025-09-18
Reason
JPMorgan
Price Target
$5
2025-09-18
initiated
Underweight
Reason
JPMorgan assumed coverage of InnovAge with an Underweight rating and $5 price target. The firm views current outpatient environment to be most favorable for companies with lower reimbursement exposure to federal funding. The analyst believes InnovAge is facing challenges balancing growth while navigating the regulatory backdrop.
JP Morgan
Lisa Gill
Hold
to
Sell
Downgrades
$5
2024-12-17
Reason
JP Morgan
Lisa Gill
Price Target
$5
2024-12-17
Downgrades
Hold
to
Sell
Reason
JPMorgan downgraded InnovAge to Underweight from Neutral with a $5 price target. The company operates within a sensitive market and is subject to higher scrutiny from both state and federal regulators, which has presented an extended headwind to growth prospects over the past three years, the analyst tells investors in a research note. The firm cites lingering headwinds to InnovAge's long-term growth prospects presented by regulatory scrutiny from both state and federal regulators for the downgrade.
See All Ratings

Valuation Metrics

The current forward P/E ratio for InnovAge Holding Corp (INNV.O) is 21.02, compared to its 5-year average forward P/E of -48.43. For a more detailed relative valuation and DCF analysis to assess InnovAge Holding Corp 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-48.43
Current PE
21.02
Overvalued PE
1088.22
Undervalued PE
-1185.08

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-3.86
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
190.99
Undervalued EV/EBITDA
-198.71

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
1.32
Current PS
0.00
Overvalued PS
2.38
Undervalued PS
0.26
Intellectia AI SwingMax
Intellectia AI SwingMax

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds areSelling! The selling amount has increased 105.94% over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Financial AI Agent
Financial AI Agent

INNV News & Events

Events Timeline

(ET)
2025-11-03
17:03:24
InnovAge names Paul Taheri as its new chief medical officer.
select
2025-09-23 (ET)
2025-09-23
08:15:14
InnovAge Names Delk as Executive Vice President and Chief Administrative Officer
select
2025-09-09 (ET)
2025-09-09
16:31:47
InnovAge projects FY26 revenue between $900M and $950M, with consensus at $938.25M
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
8.0
09-11Newsfilter
InnovAge Recognized as a Top Workplace in Aging Services™ by Fortune® and Great Place to Work®

  • InnovAge Recognition: InnovAge has been named one of the top 15 organizations in the aging services category by Fortune's Best Workplaces in Aging Services for 2025, highlighting its supportive workplace culture and commitment to high-quality care for older adults.

  • Employee Commitment: CEO Patrick Blair emphasized that the recognition reflects the dedication of InnovAge's over 2,400 employees, who are committed to providing compassionate care and fostering a positive work environment, further validated by InnovAge's sixth consecutive honor as a Great Place to Work®.

[object Object]
Preview
9.5
09-10Yahoo Finance
InnovAge Holding Corp (INNV) Q4 2025 Earnings Call Summary: Revenue Increase and Strategic Insights

  • Q4 and FY 2025 Financial Performance: InnovAge Holding Corp reported Q4 revenue of $221.4 million, an 11% increase year-over-year, with an adjusted EBITDA of $11.3 million. For FY 2025, total revenue reached $853.7 million, with a net loss of $35.3 million, compared to a loss of $23.2 million in FY 2024.

  • Future Outlook and Challenges: The company anticipates FY 2026 revenue between $900 million and $950 million, but faces challenges from Medicaid redeterminations and the transition to the B-28 Medicare Advantage payment model, which may impact revenue growth and census in the near term.

[object Object]
Preview
9.5
09-10NASDAQ.COM
InnovAge Sees 11% Revenue Increase in Fiscal Q4

  • Financial Performance: InnovAge reported an 11.0% increase in revenue from $199.4 million in Q4 FY2024 to $221.4 million in Q4 FY2025, with EBITDA (non-GAAP) rising 117.3% to $11.3 million, despite a net loss per share remaining unchanged at $(0.01) due to one-time expenses.

  • PACE Program Overview: The company operates a value-based healthcare model for seniors, focusing on participant growth and operational efficiency, with year-end enrollment increasing to 7,740, driven by fixed payments from Medicare and Medicaid.

  • Regulatory and Operational Challenges: InnovAge faces ongoing regulatory scrutiny and one-time charges impacting profitability, including a $10.1 million litigation settlement and asset impairments, while emphasizing the importance of compliance and cost management.

  • Future Projections: Management anticipates revenue growth of 5-11% for FY2026, with adjusted EBITDA expected to rise significantly, alongside a forecasted increase in participant census, highlighting the need for careful monitoring of costs and regulatory compliance.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is InnovAge Holding Corp (INNV) stock price today?

The current price of INNV is 5.15 USD — it has increased 1.38 % in the last trading day.

arrow icon

What is InnovAge Holding Corp (INNV)'s business?

InnovAge Holding Corp. is a healthcare delivery platform. The Company is engaged in managing the care of high-cost, frail, and dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE). Its programs are designed to allow frail seniors to live life on their terms by aging in place, in their own homes and communities, for as long as safely possible. Through its PACE program, it offers a range of medical and ancillary services for seniors, including in-home care services (skilled, unskilled and personal care), center services such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to and from the PACE center, and third-party medical appointments and care management. Its participant-centered approach is led by the Company's Interdisciplinary Care Teams (IDTs), who oversee all aspects of each participant’s care plan.

arrow icon

What is the price predicton of INNV Stock?

Wall Street analysts forecast INNV stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for INNV is 5.25 USD with a low forecast of 5.00 USD and a high forecast of 5.50 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is InnovAge Holding Corp (INNV)'s revenue for the last quarter?

InnovAge Holding Corp revenue for the last quarter amounts to 236.11M USD, increased 15.09 % YoY.

arrow icon

What is InnovAge Holding Corp (INNV)'s earnings per share (EPS) for the last quarter?

InnovAge Holding Corp. EPS for the last quarter amounts to 0.06 USD, decreased -250.00 % YoY.

arrow icon

What changes have occurred in the market's expectations for InnovAge Holding Corp (INNV)'s fundamentals?

The market is revising Downward the revenue expectations for InnovAge Holding Corp. (INNV) for FY2026, with the revenue forecasts being adjusted by -0.93% over the past three months. During the same period, the stock price has changed by 35.88%.
arrow icon

How many employees does InnovAge Holding Corp (INNV). have?

InnovAge Holding Corp (INNV) has 2440 emplpoyees as of December 05 2025.

arrow icon

What is InnovAge Holding Corp (INNV) market cap?

Today INNV has the market capitalization of 698.76M USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free